Symbiosal® and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006: (Scientific Opinion)

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Anders Mikael Sjödin

Research output: Contribution to journalJournal articlepeer-review

1 Citation (Scopus)
180 Downloads (Pure)
Original languageEnglish
Article number5364
JournalE F S A Journal
Volume16
Issue number7
Number of pages13
ISSN1831-4732
DOIs
Publication statusPublished - 25 Jul 2018

Bibliographical note

EFSA 2018 5364

Keywords

  • Faculty of Science
  • Symbiosal®
  • Chitosan
  • Blood pressure
  • Hypertension
  • Health claim

Cite this